
Strolll
Strolll develops Digital Therapeutics software for Augmented Reality (AR) glasses that empower movement therapy for people with neurological disorders.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | £10.4m | Series A | |
Total Funding | 000k |
Related Content
Strolll is a company that operates in the digital therapeutics sector, specializing in the development of software for Augmented Reality (AR) glasses. This software is designed to facilitate movement therapy for individuals with neurological disorders, such as Parkinson's disease and stroke survivors. The company's primary product is a platform that delivers personalized therapy exercises through AR, aiming to improve motor function and quality of life for its users.
The business model is likely centered around a subscription-based service for the software, or through partnerships with healthcare providers and rehabilitation centers. Strolll's target market includes individuals with neurological conditions, as well as physical and occupational therapists who can use the platform to supplement traditional therapy methods.
The software provides users with visual and auditory cues through the AR glasses, guiding them through exercises designed to improve balance, gait, and coordination. The platform also includes features for tracking progress and customizing therapy plans, allowing for a data-driven approach to rehabilitation.
Keywords: digital therapeutics, augmented reality, neurological disorders, movement therapy, rehabilitation, Parkinson's disease, stroke recovery, assistive technology, healthcare software, medical technology